The laboratory centrifuges market is projected to reach USD 2.2 billion by 2026 from USD 1.8 billion in 2021, at a CAGR of 4.0% from 2021 to 2026. A centrifuge is used for spinning a liquid sample at high speeds to separate it into its components. Subjected to centrifugal force, the lighter components of the liquid sample move towards the axis while the denser components move away. Centrifuges are widely used in laboratories for research purposes in chemistry, biology, and biochemistry. Centrifuges are widely used in research that requires the separation of various components. While this equipment has a long lifespan, it requires proper maintenance and care by trained professionals. Various bodies govern the manufacturing of such equipment to ensure the safety and efficiency of the performance. They are widely used from academic to clinical research for the separation/purification of cells, subcellular organelles, viruses, proteins, and nucleic acids. Factors such as increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges are supporting the growth of this market. The Asia Pacific market is estimated to be the fastest-growing regional market, mainly due to the presence of emerging economies such as China and India and the increasing R&D investments by pharmaceutical & biotechnology companies in this region.
The laboratory centrifuges market is highly consolidated in nature, with few well-established players operating in the overall market. The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), and Eppendorf AG (Germany), KUBOTA Corporation (Japan), Sigma Laborzentrifugen GmbH (Germany), NuAire (US), Sartorius AG (Germany), Andreas Hettich GmbH & Co.KG (Germany), HERMLE Labortechnik GmbH (Germany), Cardinal Health (US), Agilent Technologies (US), Centurion Scientific (UK), QIAGEN N.V. (Netherlands), and Bio-Rad Laboratories, Inc. (US).
To know about the assumptions considered for the study download the pdf brochure
Thermo Fishers Scientific Inc. (US)
Thermo Fisher Scientific, Inc. (US) was the leading player in the global laboratory centrifuges market, in 2020. The company’s strong brand recognition and extensive product portfolio in the laboratory centrifuges market is its key strength. To maintain a leading position in the market, the company focuses on R&D activities to develop and introduce new products in the market.
The company increased its R&D expenditure from USD 1,003 million in 2019 to USD 1,181 million in 2020. Thermo Fisher Scientific has a robust promotional strategy in place and participates in various trade exhibitions, seminars, and workshops to promote its products.
The company geographically operates in more than 600 locations across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Danaher Corporation (US) was the second-largest player in the global laboratory centrifuges market, in 2020. The acquisition of Beckman Coulter in 2011 made Danaher a key competitor in the laboratory centrifuges market. This acquisition helped Danaher to expand its product portfolio in the area of clinical diagnostics through the addition of new and complementary product offerings. The company also focuses on product development, which led to the release of the Avanti JXN-30 centrifuge. In the past few years, Danaher focused on the strengthening of its business over four decades by acquiring and integrating new companies into a unified whole, improving them through a group of distinctive management practices known as the Danaher Business System (DBS).
The company operates in North America, Europe, and the Asia Pacific, with 242 manufacturing and distribution facilities worldwide.
Eppendorf AG (Germany)
Eppendorf AG (Germany) was the third-largest player in the global laboratory centrifuges market 2020. The company’s leading position in the market can be attributed to its focus on product innovation. The company focuses on the development of its R&D capabilities, core competence, and on meeting customer and market demands. This has allowed Eppendorf to introduce innovative products in the market. In the last two years, the company launched its Multipurpose Centrifuge 5910 Ri, Refrigerated 24-place centrifuge 5425 R, and Refrigerated 24-place centrifuge 5425. This strengthened the company’s product portfolio, brand recognition and helped it to maintain its position in the market. The company has a strong presence in Europe, North America, South America, Asia Pacific, and Africa. It also has subsidiaries in more than 28 countries.
In July 2020, Eppendorf AG acquired a Japan-based centrifuge manufacturing company, Koki Holdings Co., Ltd. (Japan), which was later known as the brand name of Himac. Eppendorf Himac Technologies Co., Ltd provides a range of robust high-speed, ultra-speed, and other varieties of centrifuges.
Laboratory Centrifuges Market by Product (Equipment(Microcentrifuge, Ultracentrifuge), Accessories(Tube, Plate)), Model(Benchtop), Rotor Design(Swinging-bucket), Intended Use(Clinical), Application(Diagnostics), End User(Hospitals) - Global Forecast to 2026
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE